Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    PBI-4050 | Idiopathic Pulmonary Fibrosis
Previous Study | Return to List | Next Study

A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02538536
Recruitment Status : Completed
First Posted : September 2, 2015
Last Update Posted : April 17, 2019
Sponsor:
Information provided by (Responsible Party):
Liminal BioSciences Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2017
Actual Study Completion Date : January 2017